Phase I/II Study of Intrathecal Administration of Recombinant Human Hepatocyte Growth Factor in Patients with Acute Spinal Cord Injury: A Double-Blind, Randomized Clinical Trial of Safety and Efficacy - Nagoshi, Narihito; Tsuji, Osahiko; Kitamura, Kazuya; Suda, Kota; Maeda, Takeshi; Yato, Yoshiyuki; Abe, Takayuki; Hayata, Daichika; Matsumoto, Morio; Okano, Hideyuki; Nakamura, Masaya (Journal of neurotrauma, 2020)
Keywords: Amyotrophic lateral sclerosis; Analysis of covariance; Animal models; Blindness; Clinical trials; Disease; Double-blind studies; Drug dosages; Growth factors; Hepatocyte growth factor; Informed consent; Patients; Registration; Spinal cord injuries; Standard deviation; Studies; clinical trial; SCI; hepatocyte growth factor